Biophotonics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Technology (Surface Imaging, Inside Imaging, See-through Imaging, Microscopy, Biosensors, Medical Lasers, Spectromolecular, Others), By Region, By Competition Forecast & Opportunities, 2018-2028F

  • Industry : Healthcare
  • Pages : NA
  • Published Date : NA
Customization Enquiry

Buy Now

Summary

Report Description

Forecast Period

2024-2028

Market Size (2022)

USD 54.18 Billion

CAGR (2023-2028)

11.38%

Fastest Growing Segment

Inside Imaging

Largest Market

North America


Market Overview

Global Biophotonics Market has valued at USD 54.18 million in 2022 and is anticipated to project impressive growth in the forecast period with a CAGR of 11.38% through 2028. Biophotonics is an interdisciplinary field that combines biology and photonics (the study of light) to develop innovative technologies for biological and medical applications. These technologies leverage the interaction between light and biological tissues to enable various imaging, sensing, and diagnostic solutions.

Key Market Drivers

Rising Demand for Non-Invasive Techniques

In an era where medical science is making leaps and bounds, the quest for less invasive, more patient-friendly healthcare procedures has never been more critical. The global biophotonics market is at the forefront of this paradigm shift, capitalizing on the increasing demand for non-invasive techniques. Non-invasive procedures eliminate the need for surgical incisions, reducing pain and discomfort for patients. This is especially crucial in diagnostic imaging, where traditional methods often require invasive exploratory surgeries. Non-invasive techniques typically result in shorter recovery periods, allowing patients to return to their daily lives more swiftly. This not only enhances patient satisfaction but also reduces the burden on healthcare resources. By avoiding surgical incisions and the potential for wound-related infections and complications, non-invasive techniques offer a safer alternative for both patients and healthcare providers. Procedures that do not involve surgical cuts leave little to no scarring, contributing to improved aesthetics and patient confidence. OCT is a non-invasive imaging technique that utilizes light waves to capture high-resolution images of biological tissues. It has revolutionized ophthalmology, cardiology, and dermatology by providing detailed images of the eye, blood vessels, and skin without the need for invasive procedures. Biophotonics has led to the development of laser-based imaging techniques that can examine tissues and cells with incredible precision. These technologies, such as multiphoton microscopy and confocal laser scanning microscopy, are instrumental in non-invasive diagnostics and research. Biophotonics has paved the way for photodynamic therapy, a non-invasive treatment option for cancer and other medical conditions. PDT involves the activation of light-sensitive drugs to target and destroy abnormal cells while sparing healthy tissue. Biophotonics has enabled minimally invasive surgical procedures that utilize lasers to perform surgeries with smaller incisions. This approach reduces the trauma to patients, lowers the risk of complications, and accelerates recovery times.

Advancements in Imaging Technologies

In the ever-evolving landscape of healthcare and life sciences, imaging technologies have emerged as a vital catalyst for innovation. Within this realm, biophotonics, which combines the principles of biology with photonics, stands out as a beacon of progress. A key driving force behind the surging global biophotonics market is the continuous advancement of imaging technologies. The development of high-resolution imaging techniques has allowed researchers to visualize cellular and subcellular structures with unprecedented detail. This has profound implications for understanding disease mechanisms and developing precise treatments. Modern imaging technologies go beyond static pictures. They can capture dynamic processes within living organisms, providing insights into how biological systems function in real time. This is crucial for studying processes like blood flow, neural activity, and cell migration. Advances in multiplex imaging enable the simultaneous visualization of multiple biomarkers or molecules within a single sample. This allows for comprehensive assessments of complex biological systems and diseases. The development of non-invasive imaging techniques has reduced the need for invasive procedures, improving patient comfort and safety. Non-invasive methods are particularly valuable in diagnosing and monitoring diseases. Real-time imaging technologies, such as live-cell microscopy, have transformed our ability to study dynamic biological processes. Researchers can now observe cellular events as they happen, providing valuable insights into diseases like cancer and neurodegenerative disorders. OCT, a non-invasive imaging technique, has seen significant growth in ophthalmology and cardiology. It allows for high-resolution imaging of tissue layers and blood vessels, aiding in the early detection and management of diseases.  This advanced imaging technique enables the visualization of deep tissues at the cellular level. It has applications in neuroscience, cancer research, and regenerative medicine, facilitating groundbreaking discoveries. Biophotonics has expanded the capabilities of fluorescence imaging, allowing for the tracking of specific molecules within cells. This is invaluable for studying cellular processes and developing targeted therapies. Laser-based biophotonics has paved the way for minimally invasive surgical procedures. These techniques use lasers to precisely target and treat tissues, reducing the need for traditional open surgeries.

Precision Medicine and Personalized Healthcare

In the age of rapidly advancing medical science, precision medicine and personalized healthcare have emerged as transformative approaches to diagnosis and treatment. These innovative paradigms are making significant contributions to the global healthcare landscape and, in turn, propelling the growth of the global biophotonics market. Precision medicine involves analyzing a patient's genetic makeup to tailor medical treatments specifically to their genetic and molecular characteristics. This information helps identify genetic mutations or biomarkers associated with diseases. Personalized healthcare considers a patient's genetic, environmental, and lifestyle factors to create a personalized treatment plan. This approach allows healthcare providers to choose therapies that are more likely to be effective and have fewer side effects. By analyzing genetic and molecular data, precision medicine can detect diseases at an earlier stage, often before symptoms manifest. This early detection can lead to more successful treatments. Personalized healthcare allows for continuous monitoring of a patient's response to treatment. Adjustments can be made in real time, optimizing outcomes and minimizing adverse effects. Biophotonics technologies are instrumental in discovering and validating biomarkers. These biomarkers are crucial for identifying disease risk, predicting treatment responses, and monitoring disease progression. Biophotonics techniques, such as fluorescence imaging and multiphoton microscopy, allow for in-depth visualization of molecular processes within living organisms. This helps researchers understand disease mechanisms and evaluate treatment efficacy. Biophotonics plays a pivotal role in the development of targeted therapies. These therapies are designed to precisely target and treat abnormal cells, sparing healthy tissue and reducing side effects. Biophotonics offers non-invasive diagnostic tools, such as optical coherence tomography (OCT), which can detect early-stage diseases without invasive procedures. Real-time imaging capabilities provided by biophotonics enable continuous monitoring of treatment responses. This allows healthcare providers to adjust treatment plans as needed for each patient.

Research and Development Investments

n the rapidly evolving landscape of healthcare and life sciences, the global biophotonics market has emerged as a beacon of innovation, offering a promising pathway for the diagnosis, treatment, and understanding of diseases. A pivotal factor fueling its growth is substantial investments in research and development (R&D). R&D investments are a cornerstone of progress in various industries, and healthcare and life sciences are no exception. In the context of biophotonics, these investments have led to groundbreaking advancements in technologies that leverage the interaction between light and biological tissues. R&D efforts drive the development of innovative biophotonics technologies. These technologies are critical for addressing complex healthcare challenges, from early disease detection to personalized treatment. Substantial R&D funding has enabled the creation of advanced imaging technologies, such as optical coherence tomography (OCT), fluorescence imaging, and multiphoton microscopy. These techniques provide high-resolution, real-time imaging of biological tissues, essential for diagnosis and research. R&D investments are crucial for the development of targeted therapies that utilize biophotonics techniques to precisely target and treat specific cells or tissues, minimizing collateral damage to healthy tissue. Biomarkers are vital for early disease detection and treatment monitoring. R&D investments support the discovery and validation of new biomarkers, which are often detected and analyzed using biophotonics methods. R&D funding has led to the creation of lab-on-a-chip devices that integrate biophotonics for rapid and portable diagnostic applications. These devices have significant potential in point-of-care settings and resource-constrained environments.


Download Free Sample Report

Key Market Challenges

High Development Costs

Biophotonics technologies require substantial investments in research, development, and manufacturing. The costs associated with developing cutting-edge imaging systems, spectroscopy tools, and laser technologies can be prohibitively high. This poses a barrier to entry for smaller companies and research institutions, limiting the diversity of market participants.

Regulatory Hurdles

The global biophotonics market operates in a highly regulated environment, especially in healthcare applications. Obtaining regulatory approvals, such as FDA clearance in the United States or CE marking in Europe, can be a lengthy and costly process. This can delay the market entry of new biophotonics products and technologies.

Skilled Workforce

Biophotonics requires a highly skilled workforce with expertise in both biology and photonics. Recruiting and retaining such talent can be challenging. Moreover, there is a need for interdisciplinary collaboration between researchers and professionals from different domains, which can sometimes be hindered by communication barriers.

Market Competition

The global biophotonics market is becoming increasingly competitive, with established players and new entrants vying for market share. This competition can drive down prices and profit margins, making it challenging for companies to sustain innovation and profitability.

Key Market Trends

Miniaturization and Portability

Miniaturization is a buzzword in the biophotonics market. As technology shrinks, biophotonics devices are becoming more compact and portable. Handheld imaging systems, point-of-care diagnostic tools, and lab-on-a-chip devices are on the rise. These advancements enable biophotonics to reach remote and resource-constrained areas, transforming healthcare accessibility.

Artificial Intelligence (AI) Integration

AI is revolutionizing data analysis and interpretation in biophotonics. Machine learning algorithms can rapidly process the vast amounts of data generated by biophotonics technologies, aiding in image analysis, diagnostics, and treatment optimization. AI-driven biophotonics promises to enhance precision and efficiency in healthcare.

Advanced Spectroscopy Techniques

Spectroscopy is a cornerstone of biophotonics, and new advanced techniques are emerging. Raman spectroscopy, hyperspectral imaging, and terahertz spectroscopy are gaining prominence. These techniques provide valuable insights into molecular structures, biomarkers, and tissue composition, enabling more accurate disease diagnosis and monitoring.

Biophotonics in Neurology

Biophotonics is making significant inroads into neuroscience. Technologies like functional near-infrared spectroscopy (fNIRS) and multiphoton microscopy are enhancing our understanding of brain function. They are valuable tools for studying neurodegenerative diseases, brain injuries, and psychiatric disorders.

Segmental Insights

Technology Insights

In the technology sector of the biophotonics market, it is anticipated that within the projected timeframe, the largest market share will belong to inside imaging, specifically endoscopy. Endoscopy is a medical procedure employed to visually inspect the internal regions of the body. This procedure utilizes a specialized instrument called an endoscope to examine the interior of hollow organs or cavities within the body. Unlike many other medical imaging methods, endoscopes are inserted directly into the organ being examined.

The integration of detection, characterization, diagnosis, and staging during endoscopic procedures remains an unmet medical requirement. The advent of biophotonics in the realm of endoscopy has unlocked fresh possibilities and presented significant and novel prospects for the improved identification and biochemical characterization of diseases. The most suitable and valuable approach for categorizing biophotonic endoscopic techniques is based on their capacity to furnish functional and biochemical data and enhance spatial resolution. Among the commonly utilized visualization technologies are second harmonic generation (SHG), frequency-domain angle-resolved low coherence interferometry (fa/LCI), and near-infrared (near-IR) technologies.

One of the most valuable applications of biophotonics in the field of medicine is photodynamic therapy. This therapeutic approach is employed for treating cancer, and it can also be utilized for conditions such as acne and psoriasis. Such applications of these technologies are driving the demand within the biophotonics market.

Regional Insights

Currently, North America holds a dominant position in the biophotonics market and is anticipated to maintain its leadership for several more years. The United States, in particular, plays a pivotal role in the biophotonics industry. Moreover, the emergence of nanotechnology has significantly propelled the biophotonics market within the United States.

In November 2020, Jenoptik Light and Optics Biophotonics Group secured multiple new development contracts in North America. The first contract pertains to the design of a camera system for an advanced fiber-optic medical device intended for use in a robotic surgical instrument. The second development initiative involves designing various subcomponents for an ophthalmology surgery system for a prominent eye care company. For the third project, Jenoptik is collaborating with a major global provider of medical laboratory equipment to deliver an advanced automated microscope for real-time cellular analysis. The fourth endeavor represents an extension of an enduring partnership with a medical diagnostics firm that specializes in point-of-care (POC) serology tests.

The significant strides in technology have elevated the role of optical techniques in addressing medical and life science-related challenges. Optical technology finds applications in various fields, encompassing the clinical treatment of patients and investigations conducted at the molecular level. The United States has seen a surge in the number of conferences dedicated to exploring advancements in biophotonics and other optical techniques. Notably, the Optical Society organized the OSA Biophotonics Congress, where discussions revolved around progress made in areas such as optical instrumentation, life science imaging, molecular probe development, and more. Additionally, the United States Congress has allocated funds from the FY20120 budget to explore opportunities for biophotonics in gene therapy research, immunotherapy research, Alzheimer's research, and various other projects. These funds are also earmarked to promote the expansion of medical technology manufacturing within the United States.


Download Free Sample Report

Recent Developments   

  • In November 2021, Oxford Instruments introduced the BC43, a compact microscopy apparatus. This innovative device has the capability to furnish users with real-time 3D imaging capabilities.
  • In March of the year 2021, Zeiss expanded its footprint in North America by inaugurating a fresh research and development, manufacturing, sales, and customer service hub in the United States, involving a substantial investment of USD 180 million. This new facility will encompass the X-ray Microscopy division and the ZEISS Microscopy Customer Center, aimed at offering comprehensive support for endeavors in materials research, life sciences, and industrial applications.

Key Market Players

  • Thermo Fisher Scientific Inc
  • Nu Skin Enterprises Inc
  • Becton Dickinson & Co
  • Glenbrook Technologies Inc
  • HAMAMATSU PHOTONICS K.K.
  • Olympus Corp
  • Carl Zeiss AG
  • Oxford Instruments PLC
  • ZENALUX BIOMEDICAL, INC.
  • PerkinElmer Health Sciences Inc

 By Technology

By Region
  • Surface Imaging, Inside Imaging
  • See-through Imaging
  • Microscopy
  • Biosensors
  • Medical Lasers
  • Spectromolecular
  • Others
  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East & Africa
 

Report Scope:

In this report, the Global Biophotonics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

  • Biophotonics Market, By Technology:

o   Surface Imaging

o   Inside Imaging

o   See-through Imaging

o   Microscopy

o   Biosensors

o   Medical Lasers

o   Spectromolecular

o   Others

  • Biophotonics Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  Germany

§  United Kingdom

§  France

§  Italy

§  Spain

o   Asia-Pacific

§  China

§  Japan

§  India

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

§  Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Biophotonics Market.

Available Customizations:

Global Biophotonics market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Global Biophotonics Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.    Markets Covered

1.2.2.    Years Considered for Study

1.2.3.    Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Voice of Customer

5.    Global Biophotonics Market Outlook

5.1.  Market Size & Forecast

5.1.1.    By Value

5.2.  Market Share & Forecast

5.2.1.    By Technology (Surface Imaging, Inside Imaging, See-through Imaging, Microscopy, Biosensors, Medical Lasers, Spectromolecular, Others)

5.2.2.    By Region

5.2.3.    By Company (2022)

5.3.  Product Market Map

5.3.1.    By Technology

5.3.2.    By Region

6.    North America Biophotonics Market Outlook

6.1.  Market Size & Forecast         

6.1.1.    By Value

6.2.  Market Share & Forecast

6.2.1.    By Technology (Surface Imaging, Inside Imaging, See-through Imaging, Microscopy, Biosensors, Medical Lasers, Spectromolecular, Others)

6.2.2.    By Country

6.3.  North America: Country Analysis

6.3.1.    United States Biophotonics Market Outlook

6.3.1.1.             Market Size & Forecast

6.3.1.1.1.            By Value

6.3.1.2.             Market Share & Forecast

6.3.1.2.1.            By Technology

6.3.2.    Canada Biophotonics Market Outlook

6.3.2.1.             Market Size & Forecast

6.3.2.1.1.            By Value

6.3.2.2.             Market Share & Forecast

6.3.2.2.1.            By Technology

6.3.3.    Mexico Biophotonics Market Outlook

6.3.3.1.             Market Size & Forecast

6.3.3.1.1.            By Value

6.3.3.2.             Market Share & Forecast

6.3.3.2.1.            By Technology

7.    Europe Biophotonics Market Outlook

7.1.  Market Size & Forecast         

7.1.1.    By Value

7.2.  Market Share & Forecast

7.2.1.    By Technology (Surface Imaging, Inside Imaging, See-through Imaging, Microscopy, Biosensors, Medical Lasers, Spectromolecular, Others)

7.2.2.    By Country

7.3.  Europe: Country Analysis

7.3.1.    Germany Biophotonics Market Outlook

7.3.1.1.             Market Size & Forecast

7.3.1.1.1.            By Value

7.3.1.2.             Market Share & Forecast

7.3.1.2.1.            By Technology

7.3.2.    United Kingdom Biophotonics Market Outlook

7.3.2.1.             Market Size & Forecast

7.3.2.1.1.            By Value

7.3.2.2.             Market Share & Forecast

7.3.2.2.1.            By Technology

7.3.3.    France Biophotonics Market Outlook

7.3.3.1.             Market Size & Forecast

7.3.3.1.1.            By Value

7.3.3.2.             Market Share & Forecast

7.3.3.2.1.            By Technology

7.3.4.    Italy Biophotonics Market Outlook

7.3.4.1.             Market Size & Forecast

7.3.4.1.1.            By Value

7.3.4.2.             Market Share & Forecast

7.3.4.2.1.            By Technology

7.3.5.    Spain Biophotonics Market Outlook

7.3.5.1.             Market Size & Forecast

7.3.5.1.1.            By Value

7.3.5.2.             Market Share & Forecast

7.3.5.2.1.            By Technology

8.    Asia-Pacific Biophotonics Market Outlook

8.1.  Market Size & Forecast         

8.1.1.    By Value

8.2.  Market Share & Forecast

8.2.1.    By Technology (Surface Imaging, Inside Imaging, See-through Imaging, Microscopy, Biosensors, Medical Lasers, Spectromolecular, Others)

8.2.2.    By Country

8.3.  Asia-Pacific: Country Analysis

8.3.1.    China Biophotonics Market Outlook

8.3.1.1.             Market Size & Forecast

8.3.1.1.1.            By Value

8.3.1.2.             Market Share & Forecast

8.3.1.2.1.            By Technology

8.3.2.    Japan Biophotonics Market Outlook

8.3.2.1.             Market Size & Forecast

8.3.2.1.1.            By Value

8.3.2.2.             Market Share & Forecast

8.3.2.2.1.            By Technology

8.3.3.    India Biophotonics Market Outlook

8.3.3.1.             Market Size & Forecast

8.3.3.1.1.            By Value

8.3.3.2.             Market Share & Forecast

8.3.3.2.1.            By Technology

8.3.4.    Australia Biophotonics Market Outlook

8.3.4.1.             Market Size & Forecast

8.3.4.1.1.            By Value

8.3.4.2.             Market Share & Forecast

8.3.4.2.1.            By Technology

8.3.5.    South Korea Biophotonics Market Outlook

8.3.5.1.             Market Size & Forecast

8.3.5.1.1.            By Value

8.3.5.2.             Market Share & Forecast

8.3.5.2.1.            By Technology

9.    South America Biophotonics Market Outlook

9.1.  Market Size & Forecast         

9.1.1.    By Value

9.2.  Market Share & Forecast

9.2.1.    By Technology (Surface Imaging, Inside Imaging, See-through Imaging, Microscopy, Biosensors, Medical Lasers, Spectromolecular, Others)

9.2.2.    By Country

9.3.  South America: Country Analysis

9.3.1.    Brazil Biophotonics Market Outlook

9.3.1.1.             Market Size & Forecast

9.3.1.1.1.            By Value

9.3.1.2.             Market Share & Forecast

9.3.1.2.1.            By Technology

9.3.2.    Argentina Biophotonics Market Outlook

9.3.2.1.             Market Size & Forecast

9.3.2.1.1.            By Value

9.3.2.2.             Market Share & Forecast

9.3.2.2.1.            By Technology

9.3.3.    Colombia Biophotonics Market Outlook

9.3.3.1.             Market Size & Forecast

9.3.3.1.1.            By Value

9.3.3.2.             Market Share & Forecast

9.3.3.2.1.            By Technology

10.  Middle East and Africa Biophotonics Market Outlook

10.1.               Market Size & Forecast         

10.1.1.  By Value

10.2.               Market Share & Forecast

10.2.1.  By Technology (Surface Imaging, Inside Imaging, See-through Imaging, Microscopy, Biosensors, Medical Lasers, Spectromolecular, Others)

10.2.2.  By Country

10.3.               MEA: Country Analysis

10.3.1.  South Africa Biophotonics Market Outlook

10.3.1.1.          Market Size & Forecast

10.3.1.1.1.         By Value

10.3.1.2.          Market Share & Forecast

10.3.1.2.1.         By Technology

10.3.2.  Saudi Arabia Biophotonics Market Outlook

10.3.2.1.          Market Size & Forecast

10.3.2.1.1.         By Value

10.3.2.2.          Market Share & Forecast

10.3.2.2.1.         By Technology

10.3.3.  UAE Biophotonics Market Outlook

10.3.3.1.          Market Size & Forecast

10.3.3.1.1.         By Value

10.3.3.2.          Market Share & Forecast

10.3.3.2.1.         By Technology

10.3.4.  Kuwait Biophotonics Market Outlook

10.3.4.1.          Market Size & Forecast

10.3.4.1.1.         By Value

10.3.4.2.          Market Share & Forecast

10.3.4.2.1.         By Technology

11.  Market Dynamics

11.1.               Drivers

11.2.               Challenges

12.  Market Trends & Developments

12.1.               Recent Development

12.2.               Mergers & Acquisitions

12.3.               Product Launches

13.  Porter’s Five Forces Analysis

13.1.               Competition in the Industry

13.2.               Potential of New Entrants

13.3.               Power of Suppliers

13.4.               Power of Customers

13.5.               Threat of Substitute Products

14.  Competitive Landscape

14.1.               Thermo Fisher Scientific Inc

14.1.1.  Business Overview

14.1.2.  Product Offerings

14.1.3.  Recent Developments

14.1.4.  Financials (As Reported)

14.1.5.  Key Personnel

14.1.6.  SWOT Analysis

14.2.               Nu Skin Enterprises Inc

14.3.               Becton Dickinson & Co

14.4.               Glenbrook Technologies Inc

14.5.               HAMAMATSU PHOTONICS K.K.

14.6.               Olympus Corp

14.7.               Carl Zeiss AG

14.8.               Oxford Instruments PLC

14.9.               ZENALUX BIOMEDICAL, INC.

14.10.             PerkinElmer Health Sciences Inc

15.  Strategic Recommendations

16.  About Us & Disclaimer

Figures and Tables

Frequently asked questions

down-arrow

The market size of the Global Biophotonics Market was estimated to be USD 54.18 Billion in 2022.

down-arrow

Thermo Fisher Scientific Inc, Nu Skin Enterprises Inc, Becton Dickinson & Co, Glenbrook Technologies Inc, HAMAMATSU PHOTONICS K.K., Olympus Corp, Carl Zeiss AG, Oxford Instruments PLC, ZENALUX BIOMEDICAL, INC., PerkinElmer Health Sciences Inc are some of the key players operating in the Global Biophotonics Market.

down-arrow

High development costs, regulatory hurdles, dearth of skilled workforce, are some of the major challenges faced by the Global Biophotonics Market in the upcoming years.

down-arrow

Advancements in imaging technologies and therapeutic applications are the major drivers for the Global Biophotonics Market.

Related Reports

profile

Sakshi Bajaal

Business Consultant
Press Release

Biophotonics Market to Grow with a CAGR of 11.38% through 2028

Sep, 2023

Advancements in technology and innovation in healthcare systems worldwide is expected to drive the Global Biophotonics Market growth in the forecast period, 2024-2028.

Why Choose Us